Welcome to the family.
This is an introduction stream, so I took the liberty to try an answer to your question here.
Hello All, my name is Colleen Erickson, working with the Evalytica team, and I am interested in keeping up-to-date with OHDSI tools and standards.
Hello! I’m Adam Wright, a senior scientist at Brigham and Women’s Hospital (part of Partners HealthCare) in Boston and an associate professor at Harvard. I’m interested in clinical decision support and clinical data mining, especially related to detecting adverse drug events (ADEs). I’m interested in looking at ways we can detect both known ADEs (i.e. from the literature of experts) more accurately and also find previously-unknown patterns of ADEs. My research website is here: http://wrightlab.bwh.harvard.edu/. I’d love to collaborate with other OHDSI members on these kinds of studies, and also look at how we could map some of the data we have to the common data model.
Hello. I am Michael Seungcheol Kang, an orthopaedic surgeon working in Asan Medical Center, Seoul, Korea. My subspecialty is pediatric orthopaedic surgery. I’m interested in various medical fields such as injury, sports, deformity, pain… And I and my research colleagues in our institute are currently converting the recent-5-years clinical data into the format of OMOP CDM version 5. I really want to collaborate with many other members.
Hello Group,
I am Amit Kumar, a CDISC SDTM Mapping Specialist working in Cytel India. Right now I have got one OMOP CDM Project for ETL creation for an observational study.
We are generating DRUG_EXPOSURE Table in which I have some doubts ,
- Should we collect all Drug Exposure data captured in raw data like Prior Medication, Study Medication ??
- Most of Medication History data does not captures date what can we about that.?
3.What are refill? can we keep them blank? - How to generate drug_exposure_id ?
Kindly guide me as our team is doing it for first time.
Welcome to the family!
This is an introduction stream, so it’s probably not a good idea to discuss detail here. I’ll start a new posting here.
But in general: For a full-fledged ETL conversion, you will run into a lot of questions like the ones above. It’s probably not a good idea to do this in the Forum piece-meal. What you need is a one-day work session. There are a few folks who will gladly do this for you, but you may have to compensate them a little bit.
Hi all,
My name is Alice Porter and I work for a company called GrandCare which is a company that creates healthcare technology to assist the elderly and disabled people.
I am on the research team, which entails researching which features should be included/ will be most useful to the users, and has helped to successfully implement a monitoring system within the device.
The GrandCare system has recently come to the UK, so I am now based in Manchester helping to implement the right kind of features and changes to assist people over here and to see how their lifestyles and environments may require a different kind of accessibility/ usage.
Really keen to connect with like-minded individuals and professionals.
This is Yu, Wenbo from China.
I was a biostatisician in Merck. Right now, I work for a innovation health company which focuses on intergrating electronic health records from hospitals in China. Right now, we have more than 40 third-class one-grade hospitals done. These hospitals are the summit in China.
I am a research manager in charge of converting the data into scientific findings with doctors.OHDSI is one of tools we are looking for the convertion. I am still learning more about it.
Furthermore, we are looking for collaboration from globalwise to help us accelerate the researches.
My name is Gregg Hanold. My day job is as Chief Technology Officer, at Bellrock Intelligence. At Bellrock I am responsible for the technology, design, implementation and deployment decisions at Bellrock. Bellrock offers an Enterprise Intelligence Platform that provides decision support through actionable intelligence for the Healthcare industry through the Network Intelligence Rx solution. As part of our Architecture, we fuse the internal and institutional data sources from our clients. Our clinical team and advisers are exploring integration of the OMOP common data model and the use of OHDSI’s open-source tools as the foundation for our Clinical Data Model.
In terms of how I’d like to help the OHDSI community: My passion is in data sciences that can lead to better clinical outcomes through advanced analytical solutions. Supporting this community provides the collaboration vehicle and a common reference from which this can be achieved.
Hey All,
My name is Roy Pardee and I’m a Data Architect at Kaiser Permanente of Washington (or as I prefer–KaPoW!) in the Health Research Institute. I’ve been very involved in the HCSRN’s Virtual Data Warehouse for a lot of years, and have a general interest in distributed health research.
My interest in the OMOP CDM was recently rekindled at the AMIA joint summit meeting last month. I’m hoping to learn how you all are using OMOP and its associated assets (especially the vocabulary!) to advance your research, and see what lessons I can learn to bring to my customers & collaborators.
1 Like
Hi all,
My name is Hassan Chaudhury. I’m a co-founder and Chief Commercial Officer at Health iQ based in London’s Tech City. We’re an analytics agency with a heritage working in the NHS with real world observational data. We now use it primarily for pharmaceutical market access but also encompassing phase iii. I am involved in developing short courses at Imperial College London on data science and also the CSA for the IMI2 Big Data for Better Outcomes (BD4BO) project. My interest is in bringing interesting data science techniques to the data we have to make more informed clinical and commissioning decisions in the spirit of sustainability and care quality. OHDSI looks very interesting and I’m happy to help the community.
Hello everyone,
I have just joined your journey on this forum!
My name is Shahed Iqbal. I am currently working in Daiichi Sankyo, Inc. as director of epidemiology in the clinical safety and pharmacovigilance department and leading the activities undertaken by the epidemiology team including conducting pre- and post-marketing studies using healthcare databases.
I am interested in getting involved in studies, participating in methods discussions, and in helping to write research papers.
When I am not working, I basically spend all of my time with my two daughters learning names and stories of all the princesses and their pets.
Hoping to have a meaningful involvement.
Best,
Shahed
Hello everybody,
My name is Van, and I am an Statistical Programmer at the Oslo School of Nursing.
I am working on a Clinical trial study which is observational and we are trying to ETL through OMOP CDM.
I will need help regarding the same
Thank you.
Hi all! I’m a researcher out of UC Denver | Anschutz (the medical campus). My current work is focused on analyzing APCD data and mapping these to the OMOP CDM. I’m excited to learn more from this community and contribute.
Greetings,
My name is Dennis Crain. I am a professor at Washington State University, located in the Pacific Northwest of the USA, where we have just opened our medical school, the Elson S. Floyd College of Medicine. The first cohort of students will begin their coursework this August! The medical school is co-located with our previously established Colleges of Nursing Pharmacy in the city of Spokane. With this new academic undertaking come many infrastructure and research opportunities. The first order of business (among many) is to rally the healthcare provider community to establish a region-wide health data repository using the common data model. While this will be an and enormous undertaking with many looming challenges it is one that is essential to the success of our health researchers and the betterment of the community members of the region.
My areas of research include healthcare robotics, augmented reality, and air quality as it relates to health and the built environment. I look forward to interacting with you as I begin this journey.
Hi Dennis, I spend several years growing up in Eastern Washington
(Yakima) and went to the WSU Extension in Richland for awhile. It is
great to hear that they have started a med school. I am collaborating
with folks on the Natural Product Drug Interaction center. Please let me
know if you have any questions about OHDSI, glad to chat further. best,
-Rich Boyce
Hi, Jessica,
My team is working on various mappings to OMOP CDM,
So if need help, ask, we can share our experience.
Greetings all!
I am a Chief Technical Architect who wants to leverage my knowledge of computer science and dive deeper into problem solving through data supporting health sciences. I am currently studying probability and statistics and excited over time to both learn and assist where I can.
Great to be a part of such a great organization and I look forward our interactions!
-Scott.
Hello all,
Excited to jump into this community; I work in healthcare analytics and have worked in basic and translational research, clinical trials, payer analytics, provider analytics, and third party claims administration. Currently focusing on clinical quality measures (process and outcome) and using new tech on old data (i.e., those unstructured data that we have ignored for too long) as well as statistical models to measure “risk” for outcomes beyond total cost of care. Looking forward to “joining the journey”. Geographically, I’m a transplant from Houston, TX to Madison, WI (Brrr). Look forward to meeting, learning from, and helping out members of the community.
Cheers,
Chris